Bioequivalence and Bioavailability Forum 16:34 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Study costs: Replicate vs. 2×2×2 [Regulatives / Guidelines]

posted by mahmoud-teaima - 2017-03-23 08:17  - Posting: # 17178
Views: 10,790

Hi Helmut,

» Calculation of costs is complicated (fixed & variable costs, blahblah). In my CRO we had a spreadsheet with 100 rows… Had a quick look (19 samples / period, last sampling 16 hours; 2×2×2 in 42 subjects vs. 2×2×4 in 22). The replicate design would be ~4% cheaper. ;-) If you hope for RSABE (for CVwR 31% 18 subjects instead of 22 for ABE) the reduction in costs would be ~12%.

Can you please help me for in the approximate estimation of cost of bioequivalence study?, would you please send me the template sheet that you use for such calculations.

Greetings.

Mahmoud Teaima, PhD.

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,619 posts in 3,961 threads, 1,212 registered users;
online 24 (1 registered, 23 guests [including 18 identified bots]).

I’m not a pessimist,
I’m just a well informed optimist.    José Saramago

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed